Details of the Drug Reposition

General Information of This Drug (ID: DM3IPSX)

Drug Name
ATLCAR.CD30.CCR4 cells   DM3IPSX
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neoplasm DISZKGEW 2A00-2F9Z Phase 1 [1]
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
Immunoproliferative disorder DISKM0P1 2B32 Phase 1 [1]
Immune System disease DISPV68Z 4A01-4B41 Phase 1 [1]
Lymphatic disease DIS57XO9 BD9Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03602157) Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and NHL